{"disease":{"id":"agitation-psychomotor","name":"agitation psychomotor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05765162","title":"Safe Brain Initiative, Operationalizing Precision Anaesthesia","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT04957238","title":"Physical Restraints in Intensive Care Unit Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03211897","title":"Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation","phase":"","overall_status":"COMPLETED","enrollment_count":737,"lead_sponsor_name":"Hennepin Healthcare Research Institute","has_results":false},{"nct_id":"NCT05783505","title":"A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use","phase":"NA","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04947553","title":"A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05658510","title":"Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false},{"nct_id":"NCT04276883","title":"Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT03226522","title":"Addressing Dementia Via Agitation-Centered Evaluation","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03899506","title":"Olanzapine Versus Midazolam for Agitation","phase":"","overall_status":"TERMINATED","enrollment_count":206,"lead_sponsor_name":"Hennepin Healthcare Research Institute","has_results":false},{"nct_id":"NCT04797715","title":"Assessing Clinical Outcomes in Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04514432","title":"Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation","phase":"","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"State University of New York - Upstate Medical University","has_results":false},{"nct_id":"NCT06736509","title":"An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":139,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04053426","title":"Agitation Follow up After Introduction of a New Patient Care Algorithm","phase":"","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT04251910","title":"Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT03208452","title":"The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Seoul National University Bundang Hospital","has_results":false},{"nct_id":"NCT03880084","title":"Delirium, Agitation/Sedation, Pain and Dyspnea in Respiratory Intensive Care Unit (NIVILIUM)","phase":"","overall_status":"UNKNOWN","enrollment_count":92,"lead_sponsor_name":"University of Modena and Reggio Emilia","has_results":false},{"nct_id":"NCT06620393","title":"Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","has_results":false},{"nct_id":"NCT03926520","title":"Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Brent Forester","has_results":false},{"nct_id":"NCT06041646","title":"Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT06217146","title":"A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.","phase":"NA","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"M. H MediCane Ltd.","has_results":false},{"nct_id":"NCT05272501","title":"CAlming Touch for People With Agitation or Other Behavioural Symptoms of DEMentia - A Randomized Feasibility Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University College Copenhagen","has_results":false},{"nct_id":"NCT03110900","title":"Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"University of Arkansas","has_results":true}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}